Research article
Tumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment
-
* Corresponding author: Marc A Bollet marc.bollet@curie.net
1 Department of Radiation Oncology, Institut Curie, 26 rue d'Ulm, 75248 Paris, France
2 Department of Biostatistics, Institut Curie, 26 rue d'Ulm, 75248 Paris, France
3 Laboratory of Nuclear Dynamics and Genome Plasticity (UMR 218), Institut Curie, 26 rue d'Ulm, 75248 Paris, France
4 Department of Tumour Biology, Institut Curie, 26 rue d'Ulm, 75248 Paris, France
5 Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75248 Paris, France
6 Department of Surgery, Institut Curie, 26 rue d'Ulm, 75248 Paris, France
7 Department of Bio-informatics, Institut Curie, 26 rue d'Ulm, 75248 Paris, France
8 INSERM, U900, 26 rue d'Ulm, 75248 Paris, France
9 Ecole des Mines de Paris, 35 rue Saint Honoré, 77300, Fontainebleau, France
Breast Cancer Research 2009, 11:R54 doi:10.1186/bcr2343
Published: 28 July 2009Additional files
Additional file 1:
Table listing primer and probe sequences, PCR efficiencies, regression coefficient and references.
Format: DOC Size: 151KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
Provides information from publicly available gene-expression studies of women, younger than 40 years old, treated with breast conserving treatments and whole breast radiotherapy.
Format: DOC Size: 103KB Download file
This file can be viewed with: Microsoft Word Viewer